Roger Lewis, MD
Family Medicine · Terra Alta, WVNPI 1568411858
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 401 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 401 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$874
- Amgen$865
- Novo Nordisk$517
- Abbott$408
- Boehringer Ingelheim$404
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,13599%
- Education$571%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $1,461 |
| AbbVie(2 entities) | 67 | $874 |
| Amgen | 59 | $865 |
| Novo Nordisk | 33 | $517 |
| Abbott | 11 | $408 |
| Boehringer Ingelheim | 23 | $404 |
| Novartis | 27 | $390 |
| Bayer | 15 | $310 |
| GSK | 17 | $288 |
| Lilly USA, LLC | 18 | $268 |
| Merck | 18 | $217 |
| Vanda Pharmaceuticals Inc. | 2 | $141 |
| Amarin Pharma, Inc. | 10 | $132 |
| Exact Sciences | 7 | $114 |
| Supernus Pharmaceuticals, Inc. | 6 | $100 |
| Pfizer | 5 | $89 |
| Mylan Specialty L.p. | 5 | $85 |
| Sunovion Pharmaceuticals Inc. | 5 | $69 |
| Lundbeck LLC | 3 | $67 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $56 |
| Intuitive Surgical | 1 | $49 |
| Verona Pharma, Inc. | 2 | $40 |
| Medtronic | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Alkermes, Inc. | 1 | $14 |
| Recor Medical Inc | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $14 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$406
- SYMBICORT$274
- BREZTRI$233
- FASENRA$158
- BREZTRI AEROSPHERE$158
- FREESTYLE LIBRE 3$145
- Creon$123
- Fanapt$119
- AIRSUPRA$118
- Kerendia$103
How this compares
$7,191 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 40 | $136,677 |
| JardianceEmpagliflozin | 300 | $133,491 |
| OzempicSemaglutide | 102 | $125,960 |
| EliquisApixaban | 217 | $121,637 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 104 | $109,877 |
| AristadaAripiprazole Lauroxil | 28 | $83,209 |
| TrulicityDulaglutide | 43 | $74,928 |
| Abilify MaintenaAripiprazole | 20 | $59,555 |
| FarxigaDapagliflozin Propanediol | 60 | $53,201 |
| MounjaroTirzepatide | 25 | $45,544 |
| EntrestoSacubitril/Valsartan | 62 | $42,403 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $30,154 |
| LinzessLinaclotide | 93 | $28,133 |
| XareltoRivaroxaban | 48 | $26,428 |
| Lupron DepotLeuprolide Acetate | 12 | $26,201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix, Anoro Ellipta, Arexvy | $288 | $166,590240 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat, Tradjenta | $404 | $156,524351 claims |
| Novo NordiskOzempic | $517 | $125,960102 claims |
| PfizerEliquis | $89 | $121,637217 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $268 | $120,47268 claims |
| Alkermes, Inc.Aristada | $14 | $83,20928 claims |
| AbbVieLinzess, Lupron Depot, Restasis, Synthroid | $874 | $66,601170 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $16 | $59,55520 claims |
| AstraZenecaFarxiga | $1,461 | $53,20160 claims |
| NovartisEntresto | $390 | $42,40362 claims |
| MerckJanuvia, Janumet Xr | $217 | $23,76841 claims |
| BayerKerendia | $310 | $6,87920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Terra Alta
- Julie DetempleSouth Charleston$129K
- John CornellHuntington$68K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
- David HessBridgeport$20K
- Cherry LobatonMartinsburg$19K
- Melissa GamponiaCharleston$18K
- Stephen MascioFollansbee$17K
- Kenneth AdkinsSouth Charleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.